Beginning in 2005, the Food & Drug Administration began passing Structured Product Labeling (SPL) rulings that require pharmaceutical manufacturers to submit drug product labels in XML. Most recently, the FDA issued SPL R4, a revision to SPL that mandates that starting June 1, 2009, all product label content must be submitted by pharmaceutical companies electronically in XML.